This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Jan;119(1 Suppl):39S-63S.

doi: 10.1378/chest.119.1_suppl.39s.

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

C Patrono¹, B Coller, J E Dalen, G A FitzGerald, V Fuster, M Gent, J Hirsh, G Roth

Affiliations

PMID: 11157642
DOI: 10.1378/chest.119.1_suppl.39s

Review

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

C Patrono et al. Chest. 2001 Jan.

. 2001 Jan;119(1 Suppl):39S-63S.

doi: 10.1378/chest.119.1_suppl.39s.

Authors

C Patrono¹, B Coller, J E Dalen, G A FitzGerald, V Fuster, M Gent, J Hirsh, G Roth

Affiliation

¹ Department of Medicine and Aging, Università degli Studi G D'Annunzio, Chieti, Italy. Cpatrono@unich.it

PMID: 11157642
DOI: 10.1378/chest.119.1_suppl.39s

No abstract available

PubMed Disclaimer

Similar articles

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
Patrono C, Coller B, Dalen JE, Fuster V, Gent M, Harker LA, Hirsh J, Roth G. Patrono C, et al. Chest. 1998 Nov;114(5 Suppl):470S-488S. doi: 10.1378/chest.114.5_supplement.470s. Chest. 1998. PMID: 9822058 Review. No abstract available.
[New antiplatelet agents].
Diez-Ewald. Diez-Ewald. Invest Clin. 2000 Sep;41(3):147-8. Invest Clin. 2000. PMID: 11029831 Spanish. No abstract available.
Aspirin in patients with coronary artery disease: is it simply irresistible?
Nair GV, Davis CJ, McKenzie ME, Lowry DR, Serebruany VL. Nair GV, et al. J Thromb Thrombolysis. 2001 Apr;11(2):117-26. doi: 10.1023/a:1011220615447. J Thromb Thrombolysis. 2001. PMID: 11406726 Review. No abstract available.
[Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
Zettl H, Schubert-Zsilavecz M. Zettl H, et al. Pharm Unserer Zeit. 2009;38(4):314-9. doi: 10.1002/pauz.200900320. Pharm Unserer Zeit. 2009. PMID: 19572349 Review. German. No abstract available.
[Antiplatelet agents--problem for cardiac surgeon].
Bochenek A, Wilczyński M. Bochenek A, et al. Kardiol Pol. 2006 Nov;64(11):1329-31. Kardiol Pol. 2006. PMID: 17165174 Review. Polish. No abstract available.

See all similar articles

Cited by

Antiplatelet agents in clinical practice and their haemorrhagic risk.
Gresele P. Gresele P. Blood Transfus. 2013 Jul;11(3):349-56. doi: 10.2450/2013.0248-12. Epub 2013 May 9. Blood Transfus. 2013. PMID: 23736925 Free PMC article. Review. No abstract available.
Genomics and Transcriptomics: The Powerful Technologies in Precision Medicine.
Khodadadian A, Darzi S, Haghi-Daredeh S, Sadat Eshaghi F, Babakhanzadeh E, Mirabutalebi SH, Nazari M. Khodadadian A, et al. Int J Gen Med. 2020 Sep 17;13:627-640. doi: 10.2147/IJGM.S249970. eCollection 2020. Int J Gen Med. 2020. PMID: 32982380 Free PMC article. Review.
NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.
Naesdal J, Brown K. Naesdal J, et al. Drug Saf. 2006;29(2):119-32. doi: 10.2165/00002018-200629020-00002. Drug Saf. 2006. PMID: 16454539 Review.
Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
De Cristofaro R, De Filippis V. De Cristofaro R, et al. Biochem J. 2003 Jul 15;373(Pt 2):593-601. doi: 10.1042/BJ20030167. Biochem J. 2003. PMID: 12689334 Free PMC article.
Aspirin in COVID-19: Pros and Cons.
Zareef R, Diab M, Al Saleh T, Makarem A, Younis NK, Bitar F, Arabi M. Zareef R, et al. Front Pharmacol. 2022 Mar 10;13:849628. doi: 10.3389/fphar.2022.849628. eCollection 2022. Front Pharmacol. 2022. PMID: 35370686 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information